United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - simvastatin (unii: agg2fn16ev) (simvastatin - unii:agg2fn16ev) - simvastatin 10 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with coronary heart disease (chd) or at high risk of chd, simvastatin tablets can be started simultaneously with diet. in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease, simvastatin tablets are indicated to: - reduce the risk of total mortality by reducing chd deaths. - reduce the risk of non-fatal myocardial infarction and stroke. - reduce the need for coronary and non-coronary revascularization procedures. simvastatin tablets are indicated to: - reduce elevated total cholesterol (to

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 2.5 mg - felodipine extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes an

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine 5 mg - felodipine extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes an

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - escitalopram oxalate (unii: 5u85dbw7lo) (escitalopram - unii:4o4s742any) - escitalopram 10 mg - escitalopram tablets are indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [see clinical studies (14.1)] . a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. escitalopram tablets are indicated for the acute treatment of generalized anxiety disorder (gad) in adults [see clinical studies (14.2)] . generalized anxiety disorder (dsm-iv) is characterized by excessive anxiety and worry (apprehensive expectation) that is persistent

United States - English - NLM (National Library of Medicine)

shanghai lantern cosmetic co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 g in 100 g - features to decrease bacteria on the skin that could cause disease. - recommended for repeated use. - use anywhere without water. le vital ® signature blossom delight hand sanitizer 

United States - English - NLM (National Library of Medicine)

shanghai lantern cosmetic co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 g in 100 g - features to decrease bacteria on the skin that could cause disease. - recommended for repeated use. - use anywhere without water. le vital ® signature dreamy glow hand sanitizer 

United States - English - NLM (National Library of Medicine)

shanghai lantern cosmetic co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 g in 100 g - features to decrease bacteria on the skin that could cause disease. - recommended for repeated use. - use anywhere without water. le vital ® signature japanese cherry blossom hand sanitizer 

United States - English - NLM (National Library of Medicine)

shanghai lantern cosmetic co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 g in 100 g - features to decrease bacteria on the skin that could cause disease. - recommended for repeated use. - use anywhere without water. le vital ® signature midnight rush hand sanitizer 

United States - English - NLM (National Library of Medicine)

lantern enterprises ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 g in 100 g - features to decrease bacteria on the skin that could cause disease. - recommended for repeated use. - use anywhere without water. le vital ® signature moon to light hand sanitizer 

United States - English - NLM (National Library of Medicine)

lantern enterprises ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - alcohol 62 g in 100 g - features to decrease bacteria on the skin that could cause disease. - recommended for repeated use. - use anywhere without water. le vital ® signature wake me up hand sanitizer